TAM
CRL icon

Tocqueville Asset Management’s Charles River Laboratories CRL Stock Holding History

Tocqueville Asset Management’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-2,400
Closed -$472K – 587
2022
Q3 		$472K Hold
2,400
– – 0.01% 453
2022
Q2 		$514K Sell
2,400
-23
-0.9% -$5.62K 0.01% 487
2022
Q1 		$688K Sell
2,423
-6
-0.2% -$1.85K 0.01% 477
2021
Q4 		$915K Hold
2,429
– – 0.01% 472
2021
Q3 		$1M Hold
2,429
– – 0.01% 446
2021
Q2 		$899K Buy
2,429
+19
+0.8% +$6.34K 0.01% 462
2021
Q1 		$698K Sell
2,410
-9
-0.4% -$2.5K 0.01% 497
2020
Q4 		$604K Buy
2,419
+19
+0.8% +$4.53K 0.01% 509
2020
Q3 		$543K Hold
2,400
– – 0.01% 476
2020
Q2 		$418K Hold
2,400
– – 0.01% 520
2020
Q1 		$303K Hold
2,400
– – 0.01% 538
2019
Q4 		$367K Buy
+2,400
New +$332K 0.01% 607
2018
Q4 		– Sell
-2,948
Closed -$397K – 761
2018
Q3 		$397K Sell
2,948
-130
-4% -$16K 0.01% 652
2018
Q2 		$346K Buy
3,078
+8
+0.3% +$865 ﹤0.01% 667
2018
Q1 		$328K Buy
3,070
+310
+11% +$33.4K ﹤0.01% 691
2017
Q4 		$302K Buy
+2,760
New +$300K ﹤0.01% 700
2014
Q3 		– Sell
-1,500
Closed -$80K – 939
2014
Q2 		$80K Hold
1,500
– – ﹤0.01% 1212
2014
Q1 		$91K Hold
1,500
– – ﹤0.01% 944
2013
Q4 		$80K Buy
+1,500
New +$75.3K ﹤0.01% 969
2013
Q3 		– Sell
-7,650
Closed -$314K – 928
2013
Q2 		$314K Buy
+7,650
New +$328K ﹤0.01% 765

Other funds holding CRL

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $65.2B AUM 39.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Tocqueville Asset Management's CRL Position: Q4 2022 in Review

Tocqueville Asset Management sold out of Charles River Laboratories (CRL) in Q4 2022, closing a stake of 2,400 shares — an estimated $472K sold.

Tocqueville Asset Management first reported a position in CRL in Q2 2013 and held it in 20 quarters. The position peaked at $1M in Q3 2021. 627 funds tracked by Wall St. Rank hold CRL as of Q4 2022.

  • Tocqueville Asset Management reported no remaining Charles River Laboratories position as of Q4 2022 after selling out during the quarter.
  • Tocqueville Asset Management sold 2,400 Charles River Laboratories shares in Q4 2022, an estimated $472K.
  • Tocqueville Asset Management first reported a position in Charles River Laboratories in Q2 2013 and held it in 20 quarters.
  • Tocqueville Asset Management's Charles River Laboratories position peaked at $1M in Q3 2021.
  • 627 funds tracked by Wall St. Rank held Charles River Laboratories as of Q4 2022.

Based on Tocqueville Asset Management's 13F filing for Q4 2022, filed 9 Feb 2023.